Search results
Results From The WOW.Com Content Network
Patient advocacy groups and activists have criticized Gilead for the drug's high price and lack of access in lower income countries, considering the disease affects an estimated 39.9 million ...
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."
The American Society of Health-System Pharmacists (ASHP) reported that 323 "active medication shortages" were reported in January–March 2024. As a result of drug scarcity, many healthcare systems were forced to either ration out essential drugs, triage patients based on the severity of their condition and their need for the drug, or both.
The drug brought in annual sales of $1.66 billion as of April 2024, according to Teva. Teva's generic launch comes days after the U.S. Food and Drug Administration tentatively approved London ...
Drug and precursor laws United Nations INCB – Single Convention on Narcotic Drugs, 1961 [1] INCB – Convention on Psychotropic Substances, 1971 [2] INCB – United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 [3] INCB "Green list" – List of Psychotropic Substances under International ...
The Government Delegation for the National Plan on Drugs (Spanish: Delegación del Gobierno para el Plan Nacional sobre Drogas, DGPNSD) is the executive body of the Spanish Ministry of Health, attached to the Secretary of State for Health, which is responsible for the management, promotion, general coordination and supervision of the services in charge of updating and executing the National ...
The FDA is expected to make a decision about the drug in early 2024. Innovative blood-disorder treatments. After approving the first CRISPR treatment, Casgevy, for sickle cell anemia, the FDA is ...
In most cases, generic products become available after the patent protections afforded to the drug's original developer expire. Once generic drugs enter the market, competition often leads to substantially lower prices for both the original brand-name product and its generic equivalents. In most countries, patents give 20 years of protection.